SCHEMBL25688462

SCHEMBL25688462

CC(=C1C(=O)Nc2ccc(Br)cc21)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNB2 O95067 3/20 0.56
▸ CDK1 P06493 3/20 0.56
▸ CCNB1 P14635 3/20 0.56
▸ CCNB3 Q8WWL7 3/20 0.56
▸ HSP90AA1 P07900 2/20 0.56
▸ CCR6 P51684 1/20 0.56
▸ TGM2 P21980 2/20 0.51
▸ CES1 P23141 1/20 0.51
▸ PDPK1 O15530 2/20 0.50
▸ MAPT P10636 1/20 0.50
▸ LRRK2 Q5S007 1/20 0.48
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ BRD4 O60885 2/20 0.44
▸ BRD2 P25440 2/20 0.44
▸ GABRA1 P14867 1/20 0.43
▸ GABRA5 P31644 1/20 0.43
▸ GABRA3 P34903 1/20 0.43
▸ GABRA2 P47869 1/20 0.43
▸ GABRB2 P47870 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10866889 0.87 PDPK1 (0.65) CCNB2CDK1CCNB1CCNB3HSP90AA1
SCHEMBL25688107 0.87 PDPK1 (0.55) CCNB2CDK1CCNB1CCNB3HSP90AA1
SCHEMBL30433730 0.87 PDPK1 (0.55) CCNB2CDK1CCNB1CCNB3HSP90AA1
SCHEMBL25688348 0.85 TGM2 (0.46) CCNB2CDK1CCNB1CCNB3HSP90AA1
SCHEMBL5618358 0.83 CCNB2 (0.60) CCNB2CDK1CCNB1CCNB3HSP90AA1
SCHEMBL2826131 0.83 CCNB2 (0.56) CCNB2CDK1CCNB1CCNB3HSP90AA1
SCHEMBL5618363 0.83 CCNB2 (0.60) CCNB2CDK1CCNB1CCNB3HSP90AA1
SCHEMBL14515157 0.83 CCNB2 (0.60) CCNB2CDK1CCNB1CCNB3HSP90AA1
SCHEMBL2826129 0.83 CCNB2 (0.56) CCNB2CDK1CCNB1CCNB3HSP90AA1
SCHEMBL13207326 0.83 CCNB2 (0.56) CCNB2CDK1CCNB1CCNB3HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104170-A1 COMPOUNDS FOR TREATING POLYQ-RELATED NEURODEGENERATIVE DISORDERS HANGZHOU JIJING PHARMACEUTICAL TECHNOLOGY LIMITED (CN) 2023-06-15 — — WO disclosed
Send feedback